BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8957707)

  • 1. Stabilization of nerve growth factor in controlled release polymers and in tissue.
    Krewson CE; Dause R; Mak M; Saltzman WM
    J Biomater Sci Polym Ed; 1996; 8(2):103-17. PubMed ID: 8957707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.
    Saltzman WM; Mak MW; Mahoney MJ; Duenas ET; Cleland JL
    Pharm Res; 1999 Feb; 16(2):232-40. PubMed ID: 10100308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport and elimination of recombinant human NGF during long-term delivery to the brain.
    Krewson CE; Saltzman WM
    Brain Res; 1996 Jul; 727(1-2):169-81. PubMed ID: 8842395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of nerve growth factor following direct delivery to brain interstitium.
    Krewson CE; Klarman ML; Saltzman WM
    Brain Res; 1995 May; 680(1-2):196-206. PubMed ID: 7663977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders.
    Cao X; Schoichet MS
    Biomaterials; 1999 Feb; 20(4):329-39. PubMed ID: 10048405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of the effects of various additives and polymers on nerve growth factor microspheres.
    Sun H; Xu F; Guo D; Liu G
    Drug Dev Ind Pharm; 2014 Apr; 40(4):452-7. PubMed ID: 23565585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled DNA delivery systems.
    Luo D; Woodrow-Mumford K; Belcheva N; Saltzman WM
    Pharm Res; 1999 Aug; 16(8):1300-8. PubMed ID: 10468035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release of nerve growth factor from biodegradable polymer microspheres.
    Camarata PJ; Suryanarayanan R; Turner DA; Parker RG; Ebner TJ
    Neurosurgery; 1992 Mar; 30(3):313-9. PubMed ID: 1620291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve guidance channels as drug delivery vehicles.
    Piotrowicz A; Shoichet MS
    Biomaterials; 2006 Mar; 27(9):2018-27. PubMed ID: 16239029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyphosphoester microspheres for sustained release of biologically active nerve growth factor.
    Xu X; Yu H; Gao S; Ma HQ; Leong KW; Wang S
    Biomaterials; 2002 Sep; 23(17):3765-72. PubMed ID: 12109702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic activity of nerve growth factor slowly released from microspheres.
    Hadlock TA; Sheahan T; Cheney ML; Vacanti JP; Sundback CA
    J Reconstr Microsurg; 2003 Apr; 19(3):179-84; discussion 185-6. PubMed ID: 12806579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.
    Lam XM; Duenas ET; Cleland JL
    J Pharm Sci; 2001 Sep; 90(9):1356-65. PubMed ID: 11745788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits.
    Pfister LA; Alther E; Papaloïzos M; Merkle HP; Gander B
    Eur J Pharm Biopharm; 2008 Jun; 69(2):563-72. PubMed ID: 18294826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer.
    Hsu TT; Langer R
    J Biomed Mater Res; 1985 Apr; 19(4):445-60. PubMed ID: 4055827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of bovine serum albumin from preformed porous microspheres of poly(L-lactic acid).
    Puri N; Jones AB; Kou JH; Wyandt CM
    J Microencapsul; 2000; 17(2):207-14. PubMed ID: 10738696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion.
    Hoffman D; Wahlberg L; Aebischer P
    Exp Neurol; 1990 Oct; 110(1):39-44. PubMed ID: 2209780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends.
    Jiang W; Schwendeman SP
    Pharm Res; 2001 Jun; 18(6):878-85. PubMed ID: 11474795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.